open access

Vol 9, No 6 (2004)
Published online: 2004-01-01
Submitted: 2004-05-15
Get Citation

Why do maxillary-ethmoidal massive tumours need combined the-rapy?

Wojciech Golusinski, Małgorzata Leszczyńska, Elżbieta Waśeniewska, Wojcięch Gawęcki
DOI: 10.1016/S1507-1367(04)71036-6
·
Rep Pract Oncol Radiother 2004;9(6):253-256.

open access

Vol 9, No 6 (2004)
Published online: 2004-01-01
Submitted: 2004-05-15

Abstract

Aim of the study

The aim of this study was to present a retrospective analysis of maxillary-ethmoidal massive malignant tumours with emphasis on the importance of interdisciplinary co-operation and treatment scheduling.

Material and methods

The investigated group consisted of 196 patients who underwent treatment at the Department of Otolaryngology and Laryngological Oncology of the Medical School in Poznań between 1977–2001. An advanced stage of the disease T3 and T4 was found in 85% of patients. No patient was in stage T1. Tumours originated from the maxillary sinus in 60% of patients, the sidewall of the nasal cavity in 30%, and the rest of the tumours from the ethmoid, frontal and sphenoid sinus. Histologically cell carcinomas occurred in most of the cases (60%), whereas adenoid-cystic carcinoma and adenocarcinoma were rare (only 15% of the cases).

Results

All patient received multidisciplinary medical treatment: surgery with complementary radio- and chemotherapy. The Denker mode like surgery, Moure’a mode lateral rynothomy, partial or total maxillectomy and midfacial degloving were carried out in patients under study. Patients after partial or total maxillectomy resection received relevant prosthetic supply. Psychologist's assistance was essential in a few cases.

Conclusions

The analysis of the clinical material indicated the necessity of interdisciplinary co-operation and combined therapy.

Abstract

Aim of the study

The aim of this study was to present a retrospective analysis of maxillary-ethmoidal massive malignant tumours with emphasis on the importance of interdisciplinary co-operation and treatment scheduling.

Material and methods

The investigated group consisted of 196 patients who underwent treatment at the Department of Otolaryngology and Laryngological Oncology of the Medical School in Poznań between 1977–2001. An advanced stage of the disease T3 and T4 was found in 85% of patients. No patient was in stage T1. Tumours originated from the maxillary sinus in 60% of patients, the sidewall of the nasal cavity in 30%, and the rest of the tumours from the ethmoid, frontal and sphenoid sinus. Histologically cell carcinomas occurred in most of the cases (60%), whereas adenoid-cystic carcinoma and adenocarcinoma were rare (only 15% of the cases).

Results

All patient received multidisciplinary medical treatment: surgery with complementary radio- and chemotherapy. The Denker mode like surgery, Moure’a mode lateral rynothomy, partial or total maxillectomy and midfacial degloving were carried out in patients under study. Patients after partial or total maxillectomy resection received relevant prosthetic supply. Psychologist's assistance was essential in a few cases.

Conclusions

The analysis of the clinical material indicated the necessity of interdisciplinary co-operation and combined therapy.

Get Citation

Keywords

maxillary-ethmoidal massive; malignant tumours; combined therapy

About this article
Title

Why do maxillary-ethmoidal massive tumours need combined the-rapy?

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 9, No 6 (2004)

Pages

253-256

Published online

2004-01-01

DOI

10.1016/S1507-1367(04)71036-6

Bibliographic record

Rep Pract Oncol Radiother 2004;9(6):253-256.

Keywords

maxillary-ethmoidal massive
malignant tumours
combined therapy

Authors

Wojciech Golusinski
Małgorzata Leszczyńska
Elżbieta Waśeniewska
Wojcięch Gawęcki

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl